fintopic.
Docs Get the API

Emcure Pharma Q2 FY27 profit jumps 29.3% to Rs 325.1 crore

8 statements from 3 sources on Nov 3, 2026, 09:04–13:13 UTC
Part of Companies & earnings
News
Updated
Front page

Statements (8)

  1. Bullish

    Emcure Pharmaceuticals posted a consolidated net profit of Rs 325.06 crore for the September quarter.

    economictimes.indiatimes.comHigh importance
  2. Bullish

    Emcure Pharma recorded a 11.1% growth in domestic business to ₹1,155.3 crore during the quarter

    business-standard.comHigh importance
  3. Bullish

    Emcure Pharma recorded a 34% growth in international business to ₹1,665.2 crore during the quarter

    business-standard.comHigh importance
  4. Bullish

    Emcure Pharma's net profit rose 29.31% to ₹325 crore in Q2FY27

    business-standard.comHigh importance
  5. Bullish

    Emcure Pharmaceuticals EBITDA rose 30.9% year over year in Q2 FY27.

    economictimes.indiatimes.comHigh importance
  6. Bullish

    Emcure Pharmaceuticals revenue grew 24.3% year over year in Q2 FY27.

    economictimes.indiatimes.comHigh importance
  7. Bullish

    Emcure Pharmaceuticals shares rose 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore.

    economictimes.indiatimes.comHigh importance
  8. Bullish

    Emcure Pharma reported EBITDA of ₹587.3 crore for the quarter, a 23.5% increase from the prior year.

    cnbctv18.com